PolyPeptide's IPO covered on day one
By Aidan Gregory 10.00 AM The IPO of PolyPeptide, the Swiss pharmaceutical ingredients company, was covered on the first morning of bookbuilding on Wednesday, according to sources close to the deal. PolyPeptide has set the price range at Sfr57 to Sfr68, implying an initial market capitalisation of Sfr1.91bn to Sfr2.24bn (€1.73bn to €2bn) – in line with expectations during pre-deal investor education. That valuation places PolyPeptide at a discount to Bachem Group and a slight premium to Lonza, ... Already a subscriber? Login
Source: globalcapital.com